Phosplatin Therapeutics

Permanently closed
Call
Website

Advertisement

1350 Avenue of the Americas Ste 2305
New York, NY 10019

Phosplatin Therapeutics, based in New York, is dedicated to addressing unmet needs in oncology immunotherapy through the development of innovative small molecule anti-cancer agents.

Their lead agent, PT-112, is a cutting-edge immunogenic cell death inducer, setting the standard as a best-in-class treatment option for cancer patients.

Generated from their website's infomation

Own this business?
See a problem?

You might also like

United StatesNew YorkNew YorkPhosplatin Therapeutics

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.

Advertisement